These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
    Author: Santamaría A, Martínez-Rubio A, Borrell M, Mateo J, Ortín R, Fontcuberta J.
    Journal: Haematologica; 2004 Jul; 89(7):880-1. PubMed ID: 15257950.
    Abstract:
    To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.
    [Abstract] [Full Text] [Related] [New Search]